⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTHS News
Pelthos Therapeutics Inc.
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
globenewswire.com
PTHS
Form 8-K
sec.gov
SBEVW
SBEV
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
globenewswire.com
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics Announces CFO Transition
globenewswire.com
PTHS
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
globenewswire.com
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
PTHS
Pelthos Therapeutics to Present at 38th Annual ROTH Conference
globenewswire.com
PTHS